Bristol Myers Squibb is committed to helping appropriate patients get access to our
medications by providing access and reimbursement support services.

This information is intended for U.S. healthcare professionals and/or healthcare professionals involved in healthcare reimbursement.

Charitable Foundation
Lookup Tool

Billing and
Diagnosis Codes

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

Reimbursement and Coding Guide for IDHIFA
Download

Filter by keyword Clear Filter
Type a keyword to find a specific NDC or ICD-10 code
National Drug Codes (NDC)1 Issued by the FDA.
59572-0705-30

COPY

50 mg/tablet enasidenib

59572-0710-30

COPY

100 mg/tablet enasidenib

International Classification of Diseases, Tenth Revision, Clinical Modification Diagnosis Codes (ICD-10-CM)2

C92

COPY

Myeloid Leukemia

C92.0

COPY

Acute myeloblastic leukemia

C92.00

COPY

Acute myeloblastic leukemia, not having achieved remission

C92.01

COPY

Acute myeloblastic leukemia, in remission

C92.02

COPY

Acute myeloblastic leukemia, in relapse

IDHIFA may be purchased through the distributors listed below.

Specialty Pharmacies

Specialty Pharmacy Phone Fax or Website
Accredo 1-877-732-3431 1-888-302-1028
http://www.accredo.com/
Biologics 1-800-850-4306 1-800-823-4506
https://www.biologicsinc.com/oncology-pharmacy-services/
CVS Caremark 1-866-388-7656 1-855-296-0210
https://www.cvsspecialty.com/wps/portal/specialty
Diplomat 1-877-977-9118 1-800-550-6272
https://www.diplomat.is
Walgreens 1-866-202-4888 1-844-371-7400
https://www.walgreens.com/pharmacy/specialtypharmacy.jsp

Community Practices

Authorized Distributor Phone Fax
Cardinal Specialty Distribution Customers 1-877-453-3972 NA
McKesson Specialty Health 1-800-482-6700 1-800-289-9285
Oncology Supply 1-800-633-7555 1-800-248-8205

For offices that prefer to use the services of a specialty pharmacy, specialty pharmacies can obtain IDHIFA from the distributors listed above.

Institutions/Hospitals

Authorized Distributor Phone Orders Fax Orders
AmerisourceBergen 1-844-222-2273 1-888-292-9774
ASD Healthcare 1-800-746-6273 1-800-547-9413
Cardinal Full Line Wholesale Customers 1-800-926-3161 NA
Cardinal Specialty Distribution Customers 1-866-677-4844 NA
McKesson Pharma 1-855-625-6285 1-800-599-9893

Puerto Rico Hospitals and Clinics

Authorized Distributor Phone Orders Fax Orders and Website
Cardinal Puerto Rico (Borschow) 1-787-625-4200 cuserv@cardinalhealth.com
https://orderexpress.cardinalhealth.com
Cesar Castillo Inc. 1-787-641-5242 (Hospitals)
1-787-641-5082 (Specialty Pharmacy)
1-787-999-1614
https://www.facilfarmaciacci.com

Above information is accurate as of 04/21.

The IDHIFA distribution program includes extended payment terms to Bristol Myers Squibb authorized IDHIFA distributors. Healthcare providers and institutions should contact their IDHIFA distributor to understand specific payment terms that may be available to them from their distributor.

Please see U.S. Full Prescribing Information for IDHIFA, including Boxed WARNING.

FDA Approval Letter as Posted by the FDA:

For the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA-approved test

View Letter

Please see U.S. Full Prescribing Information for IDHIFA, including Boxed WARNING.

Coding for IDHIFA is dependent on the insurer and the care setting in which the drug will be administered. Oncology practices need to make coding decisions based on the diagnosis and treatment of each patient and the specific insurer requirements.

Please see U.S. Full Prescribing Information for IDHIFA, including Boxed WARNING.

*Healthcare providers should code healthcare claims based upon the service that is rendered, the patient's medical record, the coding requirements of each health insurer, and best coding practices. Coding guidance provided under this heading does not provide a guarantee of reimbursement and should be considered together with all applicable coding guidance and standards. All of the coding information presented by this website is applicable to outpatient procedures only.

References:

  1. IDHIFA [package insert]. Princeton, NJ: Bristol-Myers Squibb Company.
  2. Centers for Medicare & Medicaid Services. ICD-10-CM tabular list of diseases and injuries. Accessed March 8, 2021.
    https://www.cms.gov/Medicare/Coding/ICD10/2020-ICD-10-CM.

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

Support Center icon
Support Center: 1-800-861-0048
am to 8 pm ET, Mon - Fri
Schedule a Call icon
Schedule a call from a Care CoordinatorSchedule a Call >
Request a Visit icon
Request a visit from a BMS Access & Reimbursement ManagerRequest a Visit >
Schedule a Call Request a Visit
BMS Logo

©2021 Bristol-Myers Squibb Company. All rights reserved. Access Support is a registered trademark of Bristol-Myers Squibb Company. IDHIFA® is a registered trademark of Celgene Corporation, a Bristol Myers Squibb company. IDHIFA is licensed from Agios Pharmaceuticals, Inc.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Statement. The coding, coverage, and payment information contained within this website is current as of 04/21.

2018-US-2100029 04/21